These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8619237)

  • 21. Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.
    Marino DJ; Clewell HJ; Gentry PR; Covington TR; Hack CE; David RM; Morgott DA
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):44-54. PubMed ID: 16442684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
    Bogen KT; Gold LS
    Regul Toxicol Pharmacol; 1997 Feb; 25(1):26-42. PubMed ID: 9056499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways.
    Frederick CB; Bush ML; Lomax LG; Black KA; Finch L; Kimbell JS; Morgan KT; Subramaniam RP; Morris JB; Ultman JS
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):211-31. PubMed ID: 9772217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice.
    Kawamoto Y; Matsuyama W; Wada M; Hishikawa J; Chan MP; Nakayama A; Morisawa S
    Toxicol Appl Pharmacol; 2007 Oct; 224(2):182-91. PubMed ID: 17698157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologically based pharmacokinetic model useful in prediction of the influence of species, dose, and exposure route on perchloroethylene pharmacokinetics.
    Dallas CE; Chen XM; Muralidhara S; Varkonyi P; Tackett RL; Bruckner JV
    J Toxicol Environ Health; 1995 Mar; 44(3):301-17. PubMed ID: 7897693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood concentrations of acrylonitrile in humans after oral administration extrapolated from in vivo rat pharmacokinetics, in vitro human metabolism, and physiologically based pharmacokinetic modeling.
    Takano R; Murayama N; Horiuchi K; Kitajima M; Kumamoto M; Shono F; Yamazaki H
    Regul Toxicol Pharmacol; 2010 Nov; 58(2):252-8. PubMed ID: 20600458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A physiologically based pharmacokinetic model for ethylene oxide in mouse, rat, and human.
    Fennell TR; Brown CD
    Toxicol Appl Pharmacol; 2001 Jun; 173(3):161-75. PubMed ID: 11437638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene.
    Covington TR; Robinan Gentry P; Van Landingham CB; Andersen ME; Kester JE; Clewell HJ
    Regul Toxicol Pharmacol; 2007 Feb; 47(1):1-18. PubMed ID: 16901594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiologically-based pharmacokinetic models in risk and exposure assessment.
    Blancato JN
    Ann Ist Super Sanita; 1991; 27(4):601-8. PubMed ID: 1820732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Workers' breath as a source of perchloroethylene (Perc) in the home.
    Thompson KM; Evans JS
    J Expo Anal Environ Epidemiol; 1993; 3(4):417-30. PubMed ID: 8173342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutathione conjugation of perchloroethylene in rats and mice in vitro: sex-, species-, and tissue-dependent differences.
    Lash LH; Qian W; Putt DA; Desai K; Elfarra AA; Sicuri AR; Parker JC
    Toxicol Appl Pharmacol; 1998 May; 150(1):49-57. PubMed ID: 9630452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting cancer risk from vinyl chloride exposure with a physiologically based pharmacokinetic model.
    Reitz RH; Gargas ML; Andersen ME; Provan WM; Green TL
    Toxicol Appl Pharmacol; 1996 Apr; 137(2):253-67. PubMed ID: 8661351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice.
    Greenberg MS; Burton GA; Fisher JW
    Toxicol Appl Pharmacol; 1999 Feb; 154(3):264-78. PubMed ID: 9931286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE).
    Gearhart JM; Mahle DA; Greene RJ; Seckel CS; Flemming CD; Fisher JW; Clewell HJ
    Toxicol Lett; 1993 May; 68(1-2):131-44. PubMed ID: 8516760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative evaluation of dichloroacetic acid kinetics in human--a physiologically based pharmacokinetic modeling investigation.
    Li T; Schultz I; Keys DA; Campbell JL; Fisher JW
    Toxicology; 2008 Mar; 245(1-2):35-48. PubMed ID: 18242812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly.
    Evans MV; Chiu WA; Okino MS; Caldwell JC
    Toxicol Appl Pharmacol; 2009 May; 236(3):329-40. PubMed ID: 19249323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro.
    Kedderis GL; Carfagna MA; Held SD; Batra R; Murphy JE; Gargas ML
    Toxicol Appl Pharmacol; 1993 Dec; 123(2):274-82. PubMed ID: 8248934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PBPK modeling of impact of nonalcoholic fatty liver disease on toxicokinetics of perchloroethylene in mice.
    Dalaijamts C; Cichocki JA; Luo YS; Rusyn I; Chiu WA
    Toxicol Appl Pharmacol; 2020 Aug; 400():115069. PubMed ID: 32445755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of physiologically based pharmacokinetic model for methyl tertiary-butyl ether and tertiary-butanol in male Fisher-344 rats.
    Borghoff SJ; Murphy JE; Medinsky MA
    Fundam Appl Toxicol; 1996 Apr; 30(2):264-75. PubMed ID: 8812274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A physiologically based pharmacokinetic (PB-PK) model for 1,2-dichlorobenzene linked to two possible parameters of toxicity.
    Hissink AM; Van Ommen B; Krüse J; Van Bladeren PJ
    Toxicol Appl Pharmacol; 1997 Aug; 145(2):301-10. PubMed ID: 9266803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.